ArticleBlood cancer journal2021

Superior efficacy of co-targeting GFI1/KDM1A and BRD4 against AML and post-MPN secondary AML cells.

Warren Fiskus et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.